Celldex Therapeutics | CLDX - Crediti Commerciali

Prezzo Delle Azioni
32.58
Cambio Giornaliero
0.34 1.05%
Mensile
7.92%
Annuale
83.14%
Q2 Previsione
31.36




Crediti Commerciali Cambiamento Data
AbbVie USD 12.77B 132M 2025-09
Agenus USD 22.44M 1.14M 2025-12
Amgen USD 9.57B 1.08B 2025-12
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Celldex Therapeutics USD 2.02M 1.92M 2025-12
Glaxosmithkline GBP 10.45B 707.81M 2025-12
Nektar Therapeutics USD 1.78M 1.12M 2025-12
Northwest Biotherapeutics USD 311K 299K 2025-09
Pfizer USD 18.12B 2.02B 2025-09
Rigel Pharmaceuticals USD 28.9M 1.39M 2024-06
Roche Holding CHF 11.9B 460M 2025-12